BC
Brinker Capital’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $723K | Buy |
+4,148
| New | +$723K | 0.02% | 601 |
|
|
2020
Q1 | – | Sell |
-1,658
| Closed | -$253K | – | 922 |
|
|
2019
Q4 | $253K | Sell |
1,658
-279
| -14% | -$42.6K | 0.01% | 876 |
|
|
2019
Q3 | $256K | Sell |
1,937
-187
| -9% | -$24.7K | 0.01% | 858 |
|
|
2019
Q2 | $301K | Sell |
2,124
-110
| -5% | -$15.6K | 0.01% | 820 |
|
|
2019
Q1 | $324K | Sell |
2,234
-116
| -5% | -$16.8K | 0.01% | 792 |
|
|
2018
Q4 | $266K | Sell |
2,350
-126
| -5% | -$14.3K | 0.01% | 764 |
|
|
2018
Q3 | $333K | Sell |
2,476
-112
| -4% | -$15.1K | 0.01% | 829 |
|
|
2018
Q2 | $291K | Sell |
2,588
-825
| -24% | -$92.8K | 0.01% | 869 |
|
|
2018
Q1 | $364K | Sell |
3,413
-1,842
| -35% | -$196K | 0.01% | 810 |
|
|
2017
Q4 | $575K | Buy |
5,255
+19
| +0.4% | +$2.08K | 0.02% | 645 |
|
|
2017
Q3 | $566K | Buy |
+5,236
| New | +$566K | 0.02% | 624 |
|
|
2017
Q2 | – | Sell |
-3,541
| Closed | -$319K | – | 698 |
|
|
2017
Q1 | $319K | Sell |
3,541
-143
| -4% | -$12.9K | 0.01% | 766 |
|
|
2016
Q4 | $281K | Buy |
+3,684
| New | +$281K | 0.02% | 597 |
|